Related Experiment Video
Updated: Jun 25, 2025
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States?
Susannah Franco1, Margaret R Hammerschlag1
1Departments of Pharmacy and Pediatrics, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA.
Insights
Neonatal ocular prophylaxis using azithromycin eye drops is not recommended. Prenatal screening and treatment of pregnant women are the most effective methods to prevent ophthalmia neonatorum, reducing unnecessary interventions.
Area of Science:
- Neonatal ophthalmology
- Infectious disease prevention
- Pharmacology
Background:
- Neonatal ocular prophylaxis with 0.5% erythromycin ointment is mandated in many US states.
- Erythromycin's efficacy against chlamydial ophthalmia is limited, and gonococcal ophthalmia incidence is low.
- A shortage of erythromycin prompts consideration of alternatives like azithromycin eye drops.
Purpose of the Study:
- To evaluate 1% azithromycin eye drops as an alternative to 0.5% erythromycin ophthalmic ointment for neonatal ocular prophylaxis.
- To assess clinical experience, side effects, resistance, logistics, pharmacokinetics, and pharmacodynamics of azithromycin eye drops.
Main Methods:
- Review of clinical data and literature on azithromycin eye drops for neonatal prophylaxis.
- Analysis of efficacy, safety, and resistance patterns.
- Consideration of pharmacokinetic and pharmacodynamic properties.
Main Results:
- Azithromycin eye drops are not considered an appropriate alternative for neonatal ocular prophylaxis.
- Prenatal screening and treatment of pregnant women is the most effective preventive strategy.
- Current mandates for universal prophylaxis may lead to unnecessary costs and potential harm.
Conclusions:
- Universal neonatal ocular prophylaxis mandates should be reconsidered.
- Focus should shift to prenatal screening and treatment to prevent neonatal ophthalmia.
- Azithromycin eye drops are not a suitable replacement for erythromycin ointment.
Introduction:
Neonatal ocular prophylaxis with 0.5% erythromycin ophthalmic ointment is mandated by law in many U.S. states despite its lack of efficacy in preventing chlamydial ophthalmia and the low incidence of gonococcal ophthalmia today. The current shortage of 0.5% erythromycin ophthalmic ointment is bringing into question what alternatives exist for neonatal ocular prophylaxis for the prevention of gonococcal ophthalmia. Providers in states with mandates are concerned with the implications of administering intramuscular ceftriaxone to every newborn. Azithromycin eye drops are being considered as an alternative.
Areas Covered:
This article discusses 1% azithromycin eye drops as an alternative to 0.5% erythromycin ophthalmic ointment. Clinical experience, side effects, resistance, logistics, pharmacokinetics, and pharmacodynamics are considered.
Expert Opinion:
Azithromycin eye drops are not an appropriate alternative to 0.5% erythromycin ophthalmic ointment for ocular prophylaxis. Prenatal screening and treatment of pregnant women is the most effective way to prevent neonatal ophthalmia. Mandates for universal prophylaxis should be withdrawn to avoid unnecessary medication administration, healthcare costs, and potential harm.
More Related Videos
09:20Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes
Published on: February 8, 2018
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment